Fecal Occult Blood Test, Colonoscopy Useful for Detecting Dasatinib-induced Colitis

Fecal Occult Blood Test, Colonoscopy Useful for Detecting Dasatinib-induced Colitis
Fecal Occult Blood Test, Colonoscopy Useful for Detecting Dasatinib-induced Colitis

A fecal occult blood test followed by a colonoscopy is a useful approach for detecting hemorrhagic colitis in patients with chronic myeloid leukemia (CML) treated with dasatinib, according to a study published in the journal Blood.1

Some patients with CML treated with a tyrosine kinase inhibitor (TKI) test positive upon a fecal occult blood test, and hemorrhagic colitis has been reported in patients treated with dasatinib. Therefore, researchers sought to examine the frequency of TKI-induced hemorrhagic colitis and evaluate the efficacy of screening with a fecal occult blood test followed by colonoscopy.

For the prospective study, investigators enrolled 30 patients with CML treated with a TKI. All patients underwent a fecal occult blood test, and researchers performed a colonoscopy in patients with a positive fecal occult blood test. When investigators pathologically identified TKI-induced hemorrhagic colitis, the TKI was interrupted and the fecal occult blood test was reassessed.

Results showed that the first fecal occult blood test was positive in one-third of patients. All patients with positive tests were treated with dasatinib and developed no symptoms of colitis.

Researchers confirmed dasatinib-induced hemorrhagic colitis in 33% of 18 patients treated with dasatinib. Endoscopy demonstrated that dasatinib-induced hemorrhagic colitis was characterized by a red flare and/or erosion and immunohistological analyses showed CD3+, CD8+, CD56+, and Granzyme B+ cytotoxic T lymphocyte infiltration.

Following discontinuation of dasatinib, all but 1 patient had a negative second fecal occult blood test. The patient with a positive test had concurrent colorectal polyps.

The findings ultimately suggest that dasatinib-induced hemorrhagic colitis may be asymptomatic and effectively detected with a fecal occult blood test followed by a colonoscopy.

Reference

1. Nishiwaki S, Maeda M, Yamada M, et al. Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients. Blood. 2016 Nov 18. doi: 10.1182/blood-2016-08-734947. [Epub ahead of print]

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs